Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients

NCT05325073 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT05325073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05325073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients
Lead sponsor
Northwestern University
Phase
Phase 4
Overall status
Active, not recruiting
Start date
February 18, 2022
Completion date
September 30, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant rejection